Bristol Myers Squibb Appoints New Regional Leader for Saudi Arabia and Gulf

Bristol Myers Squibb (BMS), a leading global biopharmaceutical company, has appointed Mayada Al-Ahmad to the position of General Manager of Saudi Arabia and Gulf Countries effective June 1, 2026. In this role, Mayada will lead the affiliate spanning Saudi Arabia, the United Arab Emirates, Kuwait, Qatar, Oman, Bahrain, and Jordan, with responsibility for advancing BMS's mission to deliver transformative medicines to patients across the region.

"As she assumes this new leadership role, Mayada's deep understanding of the Saudi and Gulf markets along with her strong regional network, position her well to lead this important affiliate into its next phase of growth. Her leadership will be instrumental in advancing our mission across the region, aligning seamlessly with national & regional health transformation priorities." said Michelle Calope, Senior Vice President | Head of Intercontinental Markets, Bristol Myers Squibb. Michelle.

Commenting on her new appointment, Mayada Al-Ahmad, General Manager, Saudi Arabia & Gulf Countries, Bristol Myers Squibb, said: "I am honored and enthusiastic to step into this pivotal role, leading Bristol Myers Squibb's efforts across Saudi Arabia and the Gulf Countries. It is a privilege to contribute to our vital mission of delivering innovative medicines and making a meaningful difference in patients' lives throughout this dynamic region. I look forward to working closely with our talented team and valued partners to further our commitment to health and scientific advancement."